This trial is active, not recruiting.

Condition type 2 diabetes
Treatments increase in activity to control weight, increase in activity to control weight.
Phase phase 3
Sponsor Sorlandet Hospital HF
Start date March 2004
End date March 2007
Trial size 220 participants
Trial identifier NCT00202748, SSHF70201


We know that changing lifestyle can prevent type 2 diabetes. The challenge is how to help people changing their lifestyle. We have people in 2 groups: half of them is meeting in grops of 10 persons (interventiongroup), the other ones are just visiting their doctor (controlgroup).

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention

Primary Outcomes

time frame:
Increase in maximum oxygen uptake
time frame:
Change in foodintake
time frame:
Change in self-reported activity
time frame:

Secondary Outcomes

Quality of life
time frame:

Eligibility Criteria

Male or female participants from 20 years up to 64 years old.

Inclusion Criteria: Diabetes risk score above 9 points. Exclusion Criteria: Persons with diabetes, serious heart disease, cancer or psychiatric disorder. They have to speak and understand Norwegian language.

Additional Information

Official title Phase 3 Study of Changing of Lifestyle by Persons in Risk of Type 2 Diabetes
Description The intervention group are meeting different healt proffesionals (nurse, doctor, eksperts on nutrition,experts on activity and experts on how to change. They have 7 meetings in groups of 10 persons over 3 months. The controlgroup are just meeting their own doctor or the doctor in the hospital 2 times a year. We tell all that small changes are making big differenses (in weight and the chanse of getting ill). Everyone is told that lack of aktivity is the main reason to obesity. Lack of activity also influense in whar you eat. herefore is activity in the "center".
Trial information was received from ClinicalTrials.gov and was last updated in December 2005.
Information provided to ClinicalTrials.gov by Sorlandet Hospital HF.